| Filing Date | T Date | Ticker | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/8/20 17:04 | 7/6/20 | SYNH | Health | Biolab | Commercial Physical & Biologi | Dineen John M. | NC | D | P | 514 | 59.11 | 0 | 9 | 99 | 17 | D | |||||||||||||||
| 3/23/20 17:06 | 3/19/20 | SYNH | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | P,Clinic | P | 48 | 36.65 | 0 | 1 | 5 | 27 | D | ||||||||||||||
| 3/23/20 17:04 | 3/20/20 | SYNH | Health | Biolab | Commercial Physical & Biologi | Meggs Jason M. | NC | O | CFO | P | 131 | 36.74 | 0 | 4 | 6 | 64 | D | ||||||||||||||
| 12/19/18 07:25 | 12/17/18 | SYNH | Health | Biolab | Commercial Physical & Biologi | Olefson Jonathan | NC | O | GC,Corp | P | 31 | 41.27 | 0 | 1 | 7 | 11 | D | ||||||||||||||
| 12/19/18 07:23 | 12/17/18 | SYNH | Health | Biolab | Commercial Physical & Biologi | Meggs Jason M. | NC | O | CFO | P | 151 | 41.25 | 0 | 4 | 11 | 38 | D | ||||||||||||||
| 9/20/16 16:01 | 9/19/16 | INCR | Health | Biolab | Commercial Physical & Biologi | Burgstahler David F | NC | DT | P | 43 | 43.19 | 30 | 1 | 3 | 40 | D | -10 | 7 | 13 | -5 | -3 | -1 | 0 | 2 | 3 | 4 | 18 | 2 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |